Amarin Corp Plc (AMRN)

[ziploc_1]

PDude...QUOTE "Pfizer is desperately lacking in new CVD drugs and this is probably a global corporate concern."

IMHO this is the key.

Pfizer is less worried about jobs for their CVD reps in Canada than about their worldwide position in CVD drugs...Hence their interest in Vascepa and, by extension,in Amarin...However, Pfizer is not yet certain of how much to offer for a BO of Amarin...Therefore, their recent deal with HLS is meant to provide them with more information as to what kind of an offer to make....If HLS sales of Vascepa in Canada and Amarin's sales of Vaskepa in Germany give a good sign, they can make an appropriate offer...However other BP's are also watching these factors play out...so Pfizer can't delay forever or Merck, Sanofi etc. may step in with their own bids and then, the price goes up.